These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 7909099)

  • 1. Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma.
    Chapel HM; Lee M; Hargreaves R; Pamphilon DH; Prentice AG
    Lancet; 1994 Apr; 343(8905):1059-63. PubMed ID: 7909099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of intravenous immune globulin in multiple myeloma.
    Chapel HM; Lee M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):21-4. PubMed ID: 8033429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Mofenson LM; Moye J; Korelitz J; Bethel J; Hirschhorn R; Nugent R
    Pediatr Infect Dis J; 1994 Jun; 13(6):477-84. PubMed ID: 8078734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological factors and risk of infection in plateau phase myeloma.
    Hargreaves RM; Lea JR; Griffiths H; Faux JA; Holt JM; Reid C; Bunch C; Lee M; Chapel HM
    J Clin Pathol; 1995 Mar; 48(3):260-6. PubMed ID: 7730490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Compromised immune function in multiple myeloma].
    Yoshida M
    Nihon Rinsho; 2007 Dec; 65(12):2238-42. PubMed ID: 18069267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Mofenson LM; Moye J; Bethel J; Hirschhorn R; Jordan C; Nugent R
    JAMA; 1992 Jul 22-29; 268(4):483-8. PubMed ID: 1352363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis.
    Raanani P; Gafter-Gvili A; Paul M; Ben-Bassat I; Leibovici L; Shpilberg O
    Leuk Lymphoma; 2009 May; 50(5):764-72. PubMed ID: 19330654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin therapy in patients with multiple myeloma.
    Chapel HM; Hargreaves R; Lee M; Pamphilon D
    Immunodeficiency; 1993; 4(1-4):77-8. PubMed ID: 8167740
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of infection in multiple trauma patients by high-dose intravenous immunoglobulins.
    Douzinas EE; Pitaridis MT; Louris G; Andrianakis I; Katsouyanni K; Karmpaliotis D; Economidou J; Syfras D; Roussos C
    Crit Care Med; 2000 Jan; 28(1):8-15. PubMed ID: 10667492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
    Günther G; Dreger B
    Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia.
    Boughton BJ; Jackson N; Lim S; Smith N
    Clin Lab Haematol; 1995 Mar; 17(1):75-80. PubMed ID: 7621634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma.
    Park S; Jung CW; Jang JH; Kim SJ; Kim WS; Kim K
    Transpl Infect Dis; 2015 Oct; 17(5):679-87. PubMed ID: 26201517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal antibody levels in children with PID receiving immunoglobulin.
    Tuerlinckx D; Florkin B; Ferster A; De Schutter I; Chantrain C; Haerynck F; Philippet P; Strengers P; Laub R
    Pediatrics; 2014 Jan; 133(1):e154-62. PubMed ID: 24366995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of Streptococcus pneumoniae serum antibodies in patients with primary immunodeficiency on regular intravenous immunoglobulin treatment.
    Simão-Gurge RM; Costa-Carvalho BT; Nobre FA; Gonzalez IG; de Moraes-Pinto MI
    Allergol Immunopathol (Madr); 2017; 45(1):55-62. PubMed ID: 27480789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.
    Léger JM; Chassande B; Musset L; Meininger V; Bouche P; Baumann N
    Brain; 2001 Jan; 124(Pt 1):145-53. PubMed ID: 11133794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
    Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
    Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of intravenous immunoglobulin prophylaxis in pediatric head trauma patients: a double-blind controlled trial.
    Gooding AM; Bastian JF; Peterson BM; Wilson NW
    J Crit Care; 1993 Dec; 8(4):212-6. PubMed ID: 8305958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous gammaglobulin in the prophylaxis of late sepsis in very-low-birth-weight infants: preliminary results of a randomized, double-blind, placebo-controlled trial.
    Bussel JB
    Rev Infect Dis; 1990; 12 Suppl 4():S457-61; discussion S461-2. PubMed ID: 2194270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2004; (1):CD000361. PubMed ID: 14973955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.